I am thrilled that we get to announce this partnership today between Flatiron Health and Caris Life Sciences launching a best-in-class WES/WTS mulyimodal Clinical-omics Database to the market. This type of DNA and RNAseq data coupled with robust clinical data and outcomes will allow oncology drug developers to find new targets, understand drug resistance and super responders, and develop more accurate biomarkers. It's also the perfect type of "golden data" to power AI drug discovery. When working at the Broad in drug discovery, I remember one of the biggest questions was about the relevance of the in vitro targets we discovered and if our disease models were reflecting real world biology. Now, with this type of data we can better understand cancer biology in the real world. I can't wait to see all the amazing science that will come from this partnership! #clinicogenomics #genomics #cancerresearch #realworlddata #drugdiscovery
ANNOUNCED TODAY: Caris Life Sciences and Flatiron Health are partnering to offer a new multimodal data offering that combines Caris’s large-scale, clinico-genomic database and Flatiron’s longitudinal clinical data. The datasets will include Whole Exome and Whole Transcriptome sequencing coverage alongside real-world patient outcomes, expanding our ability to support the preclinical stages of drug discovery, powering novel research to improve and extend the lives of people with cancer. Learn more: https://lnkd.in/e-kz6_3Y
Executive Leader and Physician Scientist | Healthtech | Data Science and Clinical Trials | Medical Device | Cross-functional leader advancing effective product development and implementation
9moYears in the making! Congrats